- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06332560
Pain in Endometriosis And the Relation to Lifestyle (PEARL)
Pain in Endometriosis And the Relation to Lifestyle: Effectiveness of a Dietary Intervention and Cognitive Behavioral Therapy in Endometriosis-associated Pain
The goal of this clinical trial is to investigate the effect of an anti-inflammatory diet intervention on health related quality of life and pain symptoms in women with endometriosis. And whether the addition of CBT enhancing this effect. The secondary objective is to investigate the effect of an anti-inflammatory diet on inflammatory characteristics in serum and menstruum samples as well as the effect on the gut and vaginal microbiome.
Participants will be randomized between standard care (control group), standard care and an anti-inflammatory diet, or standard care, anti-inflammatory diet and cognitive behavioral therapy.
Participants will follow an anti-inflammatory diet based on the Dutch Dietary Guidelines for 12 weeks. They will receive personalized dietary advice from a dietician and recipes will be available. cognitive behavioral therapy will be administered in a total of seven individual sessions led by a psychotherapist. The content of these sessions will be psycho-education regarding pain mechanisms and diet.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Emma Huijs
- Phone Number: 06-29698762
- Email: pearl-studie.verlgyn@radboudumc.nl
Study Locations
-
-
-
Nijmegen, Netherlands
- Radboud University Medical Center
-
Contact:
- E Huijs, B
-
Principal Investigator:
- A.W. Nap, MD PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age from 17 years
- Premenopausal status
- Body Mass Index (BMI) 18-30 kg/m2
- Ability to understand the explanation about the diet intervention (DI) and CBT
- Willing to follow the DI
- Willing to continue their use of food supplements
- Willing to undergo CBT
- Willing to collect menstrual effluent, and therefore willing to have two stop weeks from hormonal contraception (if applicable) during the study period.
Exclusion Criteria:
- Recurrent miscarriages (> 2)
- Eating disorder
- Diagnosed with Crohn's disease, Ulcerative Colitis, short bowel syndrome or another chronic inflammatory disease
- Self-reported celiac disease
- Vegan diet
- Smoking
- Use of immunosuppressive or psychotropic medication
- Score on FFQ > 120
- Diagnosed with severe mental disorder currently requiring treatment by psychiatrist
- NRS average score below 4 during the last month
- Participation in another intervention study
- Unable to speak Dutch or to understand the intervention
- Need for surgery during the participation in the study
- Serious pain (NRS > 4) from other origin than endometriosis
- Pregnant
- Scalp hair shorter than 4 cm
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard care (control group)
|
|
Experimental: Standard care and an anti-inflammatory diet (DI group)
|
12-week personalized dietary advice based on the Dutch Dietary Guidelines under the guidance of a dietician.
Other Names:
|
Experimental: Standard care, anti-inflammatory diet and cognitive behavioral therapy (DI + CBT group)
|
12-week personalized dietary advice based on the Dutch Dietary Guidelines under the guidance of a dietician.
Other Names:
Seven individual sessions led by a psychotherapist.
The content of the CBT will be psycho-education regarding pain mechanisms and DI.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Pain intensity assessed by the Numerical Rating Scale
Time Frame: 3 months
|
The Numerical Rating Scale (NRS) ranges from 0 (no pain) to 10 (unbearable pain), and is the most commonly used subjective measure to assess pain intensity. Patients will score there estimated average pain intensity and there highest pain intensity of the previous 7 days. Minimum value: 0 Maximum value: 10 Higher score indicates a higher level of pain intensity. |
3 months
|
Change in inflammatory characteristics in menstruum
Time Frame: 3 months
|
High-dimensional flow cytometry will be done to analyse immune cells such as T cells, B cells, monocytes, and macrophages.
Also Naturel Killer (NK) cells will be analysed.
Also in the menstruum, markers for (cluster of differentiation 56) CD56, (cluster of differentiation antigen 16) CD16, (killer immunoglobulin receptors)) KIR and (natural cytotoxicity receptors) NCR, and activation markers such as CD69 will be characterised.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Health Related Quality of Life assessed by the Endometriosis Health Profile 30
Time Frame: 3 months
|
The Endometriosis Health Profile 30 (EHP-30) is a disease-specific QoL questionnaire which is validated for use in endometriosis patients and measures the impact of the disease on physical, mental and social aspects of life. The EHP-30 is not a numerical scale. |
3 months
|
Change in general Quality of Life assessed by the Short Form 36
Time Frame: 3 months
|
The Short Form 36 (SF-36) is a multipurpose, general health survey which is applied to measure QoL on nine different domains: physical functioning, social functioning, role limitations due to physical health, role limitations due to emotional problems, emotional well-being, vitality, pain, general health, and health change. The SF-36 is not a numerical scale. |
3 months
|
Change in the composition of vaginal and intestinal microbiome
Time Frame: 3 months
|
Through 16S sRNA gene profiling the microbiome composition of faecal samples and vaginal swabs will be determined.
Vaginal and faecal samples will be stored for later microbiome analysis if the the investigators see clear differences in inflammatory profiles after the dietary intervention.
|
3 months
|
Change in Objective stress assessed by measuring scalp hair cortisol levels
Time Frame: 3 months
|
Cortisol will be extracted from hair.
The researcher will carefully collect a scalp hair sample of at least 0,5 cm thickness and sent these to the laboratory to analyze.
The most proximal part represents the most recently grown piece of hair.
Hair samples will be cut into a segment corresponding to the 4 cm closest to the scalp, reflecting cortisol secretion over the four months prior to sample collection.
Cortisol extraction from hair will be carried out using an enzyme-linked immunoassay (ELISA).
|
3 months
|
Adherence and anti-inflammatory status of the diet
Time Frame: 3 months
|
Diet quality will be assessed by the Eetscore. The Eetscore is a short (Food Frequency Questionnaire) FFQ, developed to assess the Dutch Healthy Diet 2015 (DHD2015) index. The questionnaire is composed of 40 questions assessing the frequency of consumption of food items. From the Eetscore FFQ, a DHD2015-index score can be calculated, indicating the diet quality of an individual. Ranges from 0 (unhealthy diet) - 160 (healthy diet). |
3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in sleep quality assessed by the PSQI
Time Frame: 3 months
|
Sleep quality will be assessed by a self-rated questionnaire called (Pittsburgh sleep quality index) PSQI. This questionnaire contains 19 items, generating scores for seven different components. A general score can be obtained by adding up the scores of the seven components. Currently, PSQI is the most used tool in clinical and research practice assessing sleep quality. Minimum score: 0. Maximum score: 21. Higher scores indicate worse sleep quality. |
3 months
|
Change in physical activity level assessed by the IPAQ-SF
Time Frame: 3 months
|
Physical activity level will be assessed in this study to minimise confounding. Participants will fill in the (International Physical Activity Questionnaire Shor Form) IPAQ-SF, which is one of the most widely used self-report questionnaires assessing physical activity. This questionnaire assesses physical activity of the past seven days at four levels of intensity: vigorous, moderate, walking, and sitting. The IPAQ-SF sum score is expressed in PA Metabolic Equivalent of Task (MET)-minutes per day or week. A higher score corresponds to a physically more strenuous activity. |
3 months
|
Change in Subjective stress assessed by the Perceived Stress Scale
Time Frame: 3 months
|
Perceived stress will be measured using the Perceived Stress Scale (PSS), a 10-item validated psychological instrument for measuring nonspecific perceived stress. Items are designed to score how unpredictable, uncontrollable, and overloaded respondents find their lives. Minimum value: 10. Maximum value: 50. Higher score indicates a higher level of perceived stress. |
3 months
|
Changes in pain cognitions assessed by the Pain anxiety symptom scale
Time Frame: 3 months
|
The Pain anxiety symptom scale (PASS) measures anxiety caused by pain. Questions are asked about feelings of fear of pain, cognitive anxiety, avoidance behaviour, and physiological anxiety symptoms. Minimum value: 0. Maximum value: 200. Higher score indicates a higher pain anxiety. |
3 months
|
Changes in pain cognitions assessed by the pain catastrophizing Scale
Time Frame: 3 months
|
The pain catastrophizing Scale (PCS) measures the degree of pain catastrophizing of the participant by measuring elements of helplessness and pessimism in relation to the ability to cope with the pain experience. Minimum value: 0. Maximum value: 52. Higher score indicates a higher level of catastrophizing |
3 months
|
Changes in Fatigue assessed by the checklist individual strength
Time Frame: 3 months
|
The checklist Individual Strength (CIS) is a 20-item questionnaire addressing fatigue, concentration, motivation and activity over the past two weeks. The CIS is not a numerical scale. |
3 months
|
Anti-inflammatory diet rating
Time Frame: At the end of the intervention (3 months), when completed the diet intervention
|
At the end of the intervention period, participants will evaluate the anti-inflammatory diet with a rating on scale, and several general questions concerning the taste, cost, and feasibility. Minimum value: 1 Maximum value: 10. Higher scores indicates greater satisfaction with the diet. |
At the end of the intervention (3 months), when completed the diet intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL86247.091.24
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometriosis
-
Fabio BarraCompletedEndometriosis | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis Pelvic | Endometriosis of ColonItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis | Bowel Endometriosis | Endometriosis, Rectum | Endometriosis ColonItaly
-
BioGene Pharmaceutical Ltd.WithdrawnSafety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (ELTA)Endometriosis | Endometriosis Ovary | Endometriosis, Rectum | Endometriosis ExternaSwitzerland
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of PleuraItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis, Rectum | Endometriosis, SigmoidItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownBowel Endometriosis | Endometriosis, RectumItaly
-
Ospedale Policlinico San MartinoActive, not recruitingEndometriosis, Rectum | Endometriosis of ColonItaly
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
-
Semmelweis UniversityUniversity of PecsNot yet recruitingEndometriosis | Endometriosis Ovary | Endometriosis Rectovaginal Septum
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
Clinical Trials on Anti-inflammatory diet (DI)
-
University of California, San DiegoRecruiting
-
University of California, San DiegoRecruiting
-
Universidade Nova de LisboaHospital Particular do Algarve - HPA SaúdeCompletedRheumatoid ArthritisPortugal
-
National University of Natural MedicineNational Center for Complementary and Integrative Health (NCCIH)CompletedDiabetes Mellitus, Type 2 | PrediabetesUnited States
-
Assiut UniversityNot yet recruitingInflammatory Bowel Diseases
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedCardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2Norway
-
Cairo UniversityNot yet recruiting
-
Göteborg UniversitySahlgrenska University Hospital, SwedenCompleted
-
Universidad de CaldasUniversidad Libre; Clinica Comfamiliar RisaraldaCompleted
-
Clinical Hospital Center RijekaUniversity of RijekaCompleted